A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia

Clinical trial NCT00520325 · WITHDRAWN

Trial details

NCT number: NCT00520325
Sponsor: Enzon Pharmaceuticals, Inc.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Hematologic Diseases Fever Neutropenia

Start date: 2007-06-01
Primary completion: 2009-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.